Sort   by:  
 Page size 
UnknownA novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity.
Not available
S-EPMC3227417 | biostudies-literature
UnknownA novel access to arylated and heteroarylated beta-carboline based PDE5 inhibitors.
Not available
S-EPMC4980833 | biostudies-literature
UnknownSynthesis of some dihydropyrimidine-based compounds bearing pyrazoline moiety and evaluation of their antiproliferative activity.
Not available
S-EPMC4994189 | biostudies-literature
UnknownDesign, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors.
Not available
S-EPMC4980839 | biostudies-literature
UnknownDesign, synthesis and biological evaluation of novel pyridine derivatives as anticancer agents and phosphodiesterase 3 inhibitors.
Not available
S-EPMC4980832 | biostudies-literature
UnknownFour-component synthesis of 1,2-dihydropyridine derivatives and their evaluation as anticancer agents.
Not available
S-EPMC4980840 | biostudies-literature
UnknownDesign of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors.
Not available
S-EPMC4980837 | biostudies-literature
UnknownSynthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer properties.
Not available
S-EPMC4994518 | biostudies-literature
UnknownNovel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention.
Not available
S-EPMC4993210 | biostudies-literature
UnknownA novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
Not available
S-EPMC3546530 | biostudies-literature
Sort   by:  
 Page size